Skip to main content
. 2011 Oct 25;2(10):81. doi: 10.1258/shorts.2011.011112

Table 4.

Study characteristics of provider-based interventions

Paper Study period Setting and population Design Quality Intervention Outcome
Burns et al.38 1995–1996 Two family health centres, Pittsburgh, Pennsylvania, USA; children aged up to 6 years; 448 intervention group, 529 control group Randomized controlled trial 25 1. Usual care (control group) vs.
2. Chart prompt
1 vs. 2: Immunisation with DTP4 net change 15% (P = 0.03); Immunisation with MMR 1 net change 16% (P = 0.01); Immunisation with OPV3 net change 14% (P = 0.04); Immunisation with DTP3, DTP5, HepB3 and OPV4, no statistically significant difference 1 vs. 2
Christy et al.39 1990–1991 Two hospital-based primary care centres, Rochester, New York, USA; Children aged 2 to 60 months old; Urban Controlled intervention trial 21 1. Usual care at site 2, 1 July 1991–6 December 1991 (concurrent control group) vs.
2. Nursing intervention guided by an algorithm form at site 1 during same period vs.
3. Usual care at site 1, 1 July 1990 and 30 November 1990 (retrospective control group)
Up to date with DTP/OPV/MMR/Hib aged 24–36 months net change 1 vs. 2 = 0.4%, 2 vs. 3 = 10% (significance not tested)
Fairbrother et al.47 1995–1996 Family and paediatric practices in nine neighbourhoods, New York City, USA; low socioeconomic status Randomized controlled trial 24.5 1. Usual care (control group) vs.
2. Physician bonus and feedback vs.
3. Enhanced fee for service and feedback
4. Feedback only
UTD with DTP/Hib/OPV/MMR 8 months after baseline, 1 vs. 2 net change = 19.2% (P < 0.01), no significant difference between group 3 or 4 and control group
Fiks et al.40 2004– 2005 Four urban primary care centres, Philadelphia, Pennsylvania, USA; children under 24 months old; >80% ethnic minorities Before and after study 27 1. Usual care (control group) vs.
2. Electronic Health Record-based clinical reminders
1 vs. 2: Up to date for 4DTP/3IPV/1MMR/3Hib/3HepB/1varicella In well child net change 33% (95% CI 32.2–34.6), in sick child 22% (95% CI 20.6–23.1)
Franzini et al.43 2003–2005 Paediatric and family health practices, Greater Houston, Texas, USA; children aged 12–23 months of age Before and after study 20.5 1. Usual care vs.
2. 1-hour peer-based educational lunch presentation
Immunisation rates 1 vs. 2 net change = 4% (not significant)
Harper et al.48 October 1993–October 1994 Family practice clinic (intervention), community health centre (control), St Paul, Minnesota, USA; children aged 24–35 months old; predominantly white, low socioeconomic group Controlled intervention trial 23 1. Usual care (non-equivalent control group) vs.
2. Physician chart reminder plus feedback on performance plus patient education
4:3:1 DTP/OPV/MMR respectively, 1 vs. 2= 12% net change (P <0.02)
Margolis et al.44 Not reported 44 primary care practices, North Carolina, USA; children aged 24–30 months Randomized controlled trial 28 1. Usual care (control group) vs.
2. Practice-based continuing medical education
Immunisation rates at 30 months post randomization 1 vs. 2 net change 0.6% (significance not reported)
Sinn et al.49 Not reported Ten paediatric group practices, Virginia Beach, Virginia, USA; children aged 9–30 months Before and after trial 21 1. Usual care (control group) vs.
2. ‘The physician leadership model’ including peer influence and review and goal setting with feedback
Up to date with immunisations at 24 months 1 vs. 2 net change 18.8% (P < 0.001)
Smith et al.45 1994 Children under 2 years of age; low income families Before and after study 21 1. Usual care vs.
2. Physician education plus free vaccines and assistance with billing disputes
UTD for age, 1 vs. 2, net change = 25% (P < 0.00001)
Soljak and Handford41 1985 Clinics and offices, Northland, New Zealand; all children born during study periods Controlled intervention trial for patient reminders; before and after study for provider reminders 21 1. Retrospective control group vs.
2. GP reminder vs.
3. GP reminder plus postal reminder cards
Up to date ‘with all appropriate antigens’ at 5 months 2 vs. 3 net change 0.4% (p = 0.86); 1 vs. 2 and 3 net change 4% (P = 0.034)
Szilagyi et al.42 1991–1993 Teaching hospital paediatric clinic and neighbourhood health centre, Rochester, New York, USA; children aged up to 2 years (mean ages 7–13 months); 1988 participants before randomization; urban; low socioeconomic status Randomized controlled trial 24.5 1. Usual care (control group)
2. Provider chart reminders
UTD with DTP/OPV/MMR/Hib, 1 vs. 2 net change = 3% at clinic (P = 0.3) and −2% at health centre (P = 0.5)
Taylor et al.50 Not reported Private paediatric and family clinics, King County, Washington, USA; children aged 3–19 months Randomized controlled trial 28 1. Immunisation rate feedback and assessment of current immunisation procedures
2. As above plus peer educational programme
Immunisation rate 1 vs. 2 net change = 2.2% (P = 0.24)
Waterman46 1992–1994 San Diego, California, USA; children aged 2–4 years; low socioeconomic status Controlled intervention trial 20 1. Usual care (control group)
2. Walk-in clinics plus provider education plus patient reminders plus education and health promotion
DTP/OPV/MMR (4:3:1) 1 vs. 2 net change = 12% (not significant)